EP 0983091 A4 20020410 - OBESITY PROTEIN FORMULATIONS
Title (en)
OBESITY PROTEIN FORMULATIONS
Title (de)
FORMULIERUNGEN AUF DER BASIS DES PROTEINS FÜR FETTLEIBIGKEIT
Title (fr)
COMPOSITION A BASE DE PROTEINES DE L'OBESITE
Publication
Application
Priority
- US 9800816 W 19980116
- US 3571597 P 19970117
- US 5496997 P 19970807
- US 6535297 P 19971112
Abstract (en)
[origin: WO9831390A1] The present invention is a storage-stable, soluble formulation comprising an obesity protein analog and a preservative, said formulation having a pH higher than pH 8.0. Said storage-stable, soluble formulation is useful as a multi-use pharmaceutical product for treating obesity.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 38/22 (2006.01); A61K 45/00 (2006.01); A61K 47/10 (2006.01); A61K 47/18 (2006.01); A61P 3/04 (2006.01); A61P 43/00 (2006.01); C07K 14/575 (2006.01)
CPC (source: EP)
A61K 38/2264 (2013.01); A61P 3/04 (2017.12); A61P 43/00 (2017.12); C07K 14/5759 (2013.01)
Citation (search report)
- [X] WO 9631526 A1 19961010 - AMYLIN PHARMACEUTICALS INC [US], et al
- [PX] EP 0797999 A2 19971001 - LILLY CO ELI [US]
- [E] EP 0827750 A2 19980311 - LILLY CO ELI [US]
- See references of WO 9831390A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE
DOCDB simple family (publication)
WO 9831390 A1 19980723; AU 5919998 A 19980807; CA 2277282 A1 19980723; EP 0983091 A1 20000308; EP 0983091 A4 20020410; JP 2001511180 A 20010807
DOCDB simple family (application)
US 9800816 W 19980116; AU 5919998 A 19980116; CA 2277282 A 19980116; EP 98902573 A 19980116; JP 53454298 A 19980116